Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
emanuele.cerulliirelli@uniroma1.it
Emanuele Cerulli Irelli
Ricercatore
Struttura:
DIPARTIMENTO DI NEUROSCIENZE UMANE
E-mail:
emanuele.cerulliirelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia
EPILEPSIA
2023
The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Plasma biomarker profile and clinical correlations in adult patients with tuberous sclerosis complex
NEUROLOGY
2023
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy
JAMA NEUROLOGY
2023
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy
EPILEPSIA
2023
Olfactory impairment in autoimmune encephalitis: another piece of the puzzle
JOURNAL OF NEUROLOGY
2022
Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients
ACTA NEUROLOGICA SCANDINAVICA
2022
High rates of early remission pattern in adult-onset compared with earlier-onset idiopathic generalized epilepsy: A long-term follow-up study
SEIZURE
2022
The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy
EPILEPSIA OPEN
2022
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance
FRONTIERS IN NEUROLOGY
2022
INVESTIGATING STRUCTURAL BRAIN CHANGES IN GAUCHER DISEASE TYPE 1: A MAGNETIC RESONANCE IMAGING STUDY
N.A.
2022
Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology.
FRONTIERS IN NEUROLOGY
2022
EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis
BIOMEDICINES
2022
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, RealWorld Study
NEUROLOGY AND THERAPY
2022
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
DRUGS & AGING
2022
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study
SEIZURE
2022
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
EPILEPSIA
2022
The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study
EPILEPSIA
2022
Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake
MOVEMENT DISORDERS CLINICAL PRACTICE
2022
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences
NEUROLOGY
2022
« prima
< precedente
1
2
3
4
seguente ›
ultima »
ERC
LS2_14
LS5
LS5_15
Keywords
drug resistant epilepsy
Patient history Clinical history Photosensitivity Epilepsy Reflex seizures Self-induction
late onset epilepsy of unknown etiology
clinical neurology
antiepileptic drugs
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma